107 related articles for article (PubMed ID: 10661767)
1. Non-invasive assessment of tumour cell proliferation with positron emission tomography and [76Br]bromodeoxyuridine.
Böni R; Bläuenstein P; Dummer R; von Schulthess GK; Schubiger PA; Steinert HC
Melanoma Res; 1999 Dec; 9(6):569-73. PubMed ID: 10661767
[TBL] [Abstract][Full Text] [Related]
2. [76Br]Bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice.
Ryser JE; Bläuenstein P; Rémy N; Weinreich R; Hasler PH; Novak-Hofer I; Schubiger PA
Nucl Med Biol; 1999 Aug; 26(6):673-9. PubMed ID: 10587106
[TBL] [Abstract][Full Text] [Related]
3. In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker.
Bergström M; Lu L; Fasth KJ; Wu F; Bergström-Pettermann E; Tolmachev V; Hedberg E; Cheng A; Långström B
J Nucl Med; 1998 Jul; 39(7):1273-9. PubMed ID: 9669410
[TBL] [Abstract][Full Text] [Related]
4. Elimination of nonspecific radioactivity from [76Br]bromide in PET study with [76Br]bromodeoxyuridine.
Lu L; Bergström M; Fasth KJ; Wu F; Eriksson B; Långström B
Nucl Med Biol; 1999 Oct; 26(7):795-802. PubMed ID: 10628559
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 76Br-BrdU in DNA of brain tumors after a PET study does not support its use as a proliferation marker.
Gudjonssona O; Bergström M; Kristjansson S; Wu F; Nyberg G; Fasth KJ; Långström B
Nucl Med Biol; 2001 Jan; 28(1):59-65. PubMed ID: 11182565
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of proliferating cells in vivo.
deFazio A; Leary JA; Hedley DW; Tattersall MH
J Histochem Cytochem; 1987 May; 35(5):571-7. PubMed ID: 3549891
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of [76Br]bromofluorodeoxyuridine and its validation with regard to uptake, DNA incorporation, and excretion modulation in rats.
Lu L; Bergström M; Fasth KJ; Langström B
J Nucl Med; 2000 Oct; 41(10):1746-52. PubMed ID: 11038007
[TBL] [Abstract][Full Text] [Related]
8. [76Br]Bromodeoxyuridine PET in tumor-bearing animals.
Gardelle O; Roelcke U; Vontobel P; Crompton NE; Guenther I; Bläuenstein P; Schubiger AP; Blattmann H; Ryser JE; Leenders KL; Kaser-Hotz B
Nucl Med Biol; 2001 Jan; 28(1):51-7. PubMed ID: 11182564
[TBL] [Abstract][Full Text] [Related]
9. Enumeration of 6-thioguanine-resistant tumour cells using flow cytometry and comparison with a microtitration cloning assay.
deFazio A; Heneine N; Musgrove EA; Tattersall MH
Mutat Res; 1989 Feb; 216(1):57-64. PubMed ID: 2645514
[TBL] [Abstract][Full Text] [Related]
10. Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter.
Lundkvist C; Loc'h C; Halldin C; Bottlaender M; Ottaviani M; Coulon C; Fuseau C; Mathis C; Farde L; Mazière B
Nucl Med Biol; 1999 Jul; 26(5):501-7. PubMed ID: 10473188
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization and positron emission tomography evaluation of 4-[76Br]bromodexetimide and 4-[76Br]bromolevetimide for investigations of central muscarinic cholinergic receptors.
Loc'h C; Kassiou M; Strijckmans V; Bottlaender M; Katsifis A; Schmid L; Mazière M; Lambrecht RM; Mazière B
Nucl Med Biol; 1996 Apr; 23(3):235-43. PubMed ID: 8782231
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain.
Sihver W; Fasth KJ; Horti AG; Koren AO; Bergström M; Lu L; Hagberg G; Lundqvist H; Dannals RF; London ED; Nordberg A; Långström B
J Neurochem; 1999 Sep; 73(3):1264-72. PubMed ID: 10461920
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging of muscarinic cholinergic receptors in temporal lobe epilepsy with a new PET tracer: [76Br]4-bromodexetimide.
Dupont S; Semah F; Loc'h C; Strijckmans V; Baulac M; Samson Y; Mazière B
J Nucl Med; 1999 Jun; 40(6):935-41. PubMed ID: 10452308
[TBL] [Abstract][Full Text] [Related]
15. (+)-[76Br]A-69024: a non-benzazepine radioligand for studies of dopamine D1 receptors using PET.
Kassiou M; Loc'h C; Bottlaender M; Mardon K; Ottaviani M; Coulon C; Katsifis A; Maziere B
Nucl Med Biol; 2002 Apr; 29(3):295-302. PubMed ID: 11929698
[TBL] [Abstract][Full Text] [Related]
16. Quantitative imaging and correction for cascade gamma radiation of 76Br with 2D and 3D PET.
Lubberink M; Schneider H; Bergström M; Lundqvist H
Phys Med Biol; 2002 Oct; 47(19):3519-34. PubMed ID: 12408479
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of 76Br-labeled anti-CEA antibodies in pigs; aspects of dosimetry and PET imaging properties.
Lövqvist A; Lundqvist H; Lubberink M; Tolmachev V; Carlsson J; Sundin A
Med Phys; 1999 Feb; 26(2):249-58. PubMed ID: 10076983
[TBL] [Abstract][Full Text] [Related]
18. In vitro PET evaluations in lung cancer cell lines.
Xing T; Wu F; Brodin O; Fasth KJ; Långström B; Bergström M
Anticancer Res; 2000; 20(3A):1375-80. PubMed ID: 10928046
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomographic investigations of central muscarinic cholinergic receptors with three isomers of [76Br]BrQNP.
Strijckmans V; Bottlaender M; Luo H; Ottaviani M; McPherson DW; Loc'h C; Fuseau C; Knapp FF; Mazière B
Eur J Nucl Med; 1997 May; 24(5):475-82. PubMed ID: 9142726
[TBL] [Abstract][Full Text] [Related]
20. Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomography.
Foged C; Halldin C; Loc'h C; Mazière B; Pauli S; Maziére M; Hansen HC; Suhara T; Swahn CG; Karlsson P; Farde L
Eur J Nucl Med; 1997 Oct; 24(10):1261-7. PubMed ID: 9323267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
